Skip to main content
AAN.com
Research Article
January 3, 2024
continuing medical education

Association Between Sleep Quantity and Quality in Early Adulthood With Cognitive Function in Midlife

January 23, 2024 issue
102 (2)
Letters to the Editor

Abstract

Background and Objective

Growing evidence supports an association between sleep quality and risk of dementia. However, little is known about whether objectively measured sleep duration and quality influence cognition in midlife, a period of importance for understanding the direction of the association between sleep and dementia. We examined the association between sleep duration and quality, measured when participants were in their mid-30s to late 40s, and midlife cognition assessed 11 years later among Black and White adults.

Methods

As part of the Coronary Artery Risk Development in Young Adults cohort study, sleep duration and quality were assessed objectively using wrist actigraphy and subjectively by Pittsburgh Sleep Quality Index (PSQI) at 2003–2005. During 2015–2016, we evaluated midlife cognition using the Digit Symbol Substitution Test (DSST), Stroop test, Rey Auditory Verbal Learning Test, Montreal Cognitive Assessment (MoCA), and Letter Fluency and Category Fluency tests. We used multivariable logistic regression to examine the association between sleep parameters and poor cognitive performance, which was defined as a score that was >1 SD below the mean score.

Results

The 526 participants (58% women and 44% Black) had a mean age of 40.1 ± 3.6 years at baseline, a mean sleep duration of 6.1 ± 1.1 hours, and mean sleep fragmentation index (calculated as the sum of the percentage of time spent moving and the percentage of immobile periods ≤1 minute) of 19.2 ± 8.1%, and 239 (45.6%) participants reported poor sleep as defined by a PSQI global score of >5. After adjustment for demographics, education, smoking, body mass index, depression, physical activity, hypertension, and diabetes, those in the highest vs lowest tertile of sleep fragmentation index had over twice the odds of having poor cognitive performance (>1 SD below the mean) on the DSST (odds ratio [OR] = 2.97; 95% CI 1.34–6.56), fluency (OR = 2.42; 95% CI 1.17–5.02), and MoCA test (OR = 2.29; 95% CI 1.06–4.94). The association between sleep fragmentation and cognitive performance did not differ by race or sex. Objective sleep duration or subjective sleep quality was not associated with cognition in midlife.

Discussion

Actigraphy-measured high sleep fragmentation rather than sleep duration was associated with worse cognition among middle-aged Black and White men and women. Sleep quality is important for cognitive health even as early as midlife.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (supplementary_table1.pdf)

References

1.
Ju YES, Lucey BP, Holtzman DM. Sleep and Alzheimer Disease Pathology—A Bidirectional Relationship. Nature Publishing Group; Published online 2014.
2.
Musiek ES, Ju YES, Author C. Targeting sleep and circadian function in the prevention of Alzheimer disease. JAMA Neurol. 2022;79(9):835-836.
3.
Brenowitz WD, Xiang Y, McEvoy CT, et al. Current Alzheimer disease research highlights: evidence for novel risk factors. Chin Med J (Engl). 2021;134(18):2150-2159.
4.
Blackwell T, Yaffe K, Laffan A, et al. Associations of objectively and subjectively measured sleep quality with subsequent cognitive decline in older community-dwelling men: the MrOS sleep study. Sleep. 2014;37(4):655-663.
5.
Yaffe K, Laffan AM, Harrison SL, et al. Sleep-disordered breathing, Hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA. 2011;306(6):613-619.
6.
Leng Y, Blackwell T, Stone KL, Hoang TD, Redline S, Yaffe K. Periodic limb movements in sleep are associated with greater cognitive decline in older men without dementia. Sleep. 2016;39(10):1807-1810.
7.
Jack CR, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207-216.
8.
Singh-Manoux A, Kivimaki M, Glymour MM, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ. 2012;344(7840):d7622.
9.
Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27(7):1255-1273.
10.
Baker FC, Lampio L, Saaresranta T, Polo-Kantola P. Sleep and sleep disorders in the menopausal transition. Sleep Med Clin. 2018;13(3):443-456.
11.
Alvaro PK, Roberts RM, Harris JK. A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep. 2013;36(7):1059-1068.
12.
Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323-331.
13.
Fu C, Hao W, Shrestha N, Virani SS, Mishra SR, Zhu D. Association of reproductive factors with dementia: a systematic review and dose-response meta-analyses of observational studies. EClinicalMedicine. 2022;43:101236.
14.
Virta JJ, Heikkilä K, Perola M, et al. Midlife sleep characteristics associated with late life cognitive function. Sleep. 2013;36(10):1533-1541, 1541A.
15.
Devore EE, Grodstein F, Duffy JF, Stampfer MJ, Czeisler CA, Schernhammer ES. Sleep duration in midlife and later life in relation to cognition. J Am Geriatr Soc. 2014;62(6):1073-1081.
16.
Sindi S, Johansson L, Skoog J, et al. Sleep disturbances and later cognitive status: a multi-centre study. Sleep Med. 2018;52:26-33.
17.
Sabia S, Fayosse A, Dumurgier J, et al. Association of sleep duration in middle and old age with incidence of dementia. Nat Commun. 2021;12(1):2289.
18.
Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported and measured sleep duration: how similar are they? Epidemiology. 2008;19(6):838-845.
19.
Dinapoli EA, Gebara MA, Kho T, et al. Subjective-objective sleep discrepancy in older adults with MCI and Subsyndromal depression. J Geriatr Psychiatry Neurol. 2017;30(6):316-323.
20.
Blackwell T, Yaffe K, Ancoli-Israel S, et al. Association of sleep characteristics and cognition in older community-dwelling men: the MrOS sleep study. Sleep. 2011;34(10):1347-1356.
21.
Díaz-Venegas C, Downer B, Langa KM, Wong R. Racial and ethnic differences in cognitive function among older adults in the USA. Int J Geriatr Psychiatry. 2016;31(9):1004-1012.
22.
Chen X, Wang R, Zee P, et al. Racial/ethnic differences in sleep disturbances: the multi-ethnic study of atherosclerosis (MESA). Sleep. 2015;38(6):877-888. Published online June 1, 2015.
23.
Chen C, Zissimopoulos JM. Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States. Alzheimers Dement (N Y). 2018;4:510-520.
24.
Swanson LM, Hood MM, Hall MH, et al. Associations between sleep and cognitive performance in a racially/ethnically diverse cohort: the Study of Women's Health across the Nation. Sleep. 2021;44(2):zsaa182.
25.
Zhou L, Kong J, Li X, Ren Q. Sex differences in the effects of sleep disorders on cognitive dysfunction. Neurosci Biobehav Rev. 2023;146:105067.
26.
Knutson KL, Van Cauter E, Rathouz PJ, et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch Intern Med. 2009;169(11):1055-1061.
27.
Wechsler D. Wechsler Adult Intelligence Scale--Fourth Edition (WAIS-IV) [Database Record]. APA PsycTests; 2008.
28.
MacLeod CM. Half a century of research on the stroop effect: an integrative review. Psychol Bull. 1991;109(2):163-203.
29.
Rosenberg SJ, Ryan JJ, Prifitera A. Rey Auditory-Verbal Learning Test performance of patients with and without memory impairment. J Clin Psychol. 1984;40(3):785-787.
30.
Nasreddine ZS, Phillips NA, Bédirian V, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
31.
Jacobs DR, Hahn LP, Haskell WL, Pirie P, Sidney S. Validity and reliability of short physical activity history: cardia and the Minnesota Heart health Program. J Cardiopulm Rehabil. 1989;9(11):448-459.
32.
Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1(3):385-401.
33.
Guay-Gagnon M, Vat S, Forget MF, et al. Sleep apnea and the risk of dementia: a systematic review and meta-analysis. J Sleep Res. 2022;31(5):e13589.
34.
Tranah GJ, Blackwell T, Stone KL, et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol. 2011;70(5):722-732.
35.
Leng Y, Redline S, Stone KL, Ancoli-Israel S, Yaffe K. Objective napping, cognitive decline, and risk of cognitive impairment in older men. Alzheimer's Dement. 2019;15(8):1039-1047.
36.
Li P, Gao L, Yu L, et al. Daytime napping and Alzheimer's dementia: a potential bidirectional relationship. Alzheimer's Dement. 2023;19(1):158-168. Published online March 17.
37.
Van Den Berg JF, Van Rooij FJA, Vos H, et al. Disagreement between subjective and actigraphic measures of sleep duration in a population-based study of elderly persons. J Sleep Res. 2008;17(3):295-302.
38.
Blackwell T, Yaffe K, Ancoli-Israel S, et al. Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci. 2006;61(4):405-410.
39.
Leng Y, Yaffe K. Sleep duration and cognitive aging—beyond a U-shaped association. JAMA Netw Open. 2020;3(9):e2014008.
40.
Leng Y, Ackley SF, Glymour MM, Yaffe K, Brenowitz WD. Genetic risk of Alzheimer's disease and sleep duration in non‐demented elders. Ann Neurol. 2021;89(1):177-181.
41.
Yaffe K, Nasrallah I, Hoang TD, et al. Sleep duration and white matter quality in middle-aged adults. Sleep. 2016;39(9):1743-1747.
42.
Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377.
43.
Ooms S, Overeem S, Besse K, Rikkert MO, Verbeek M, Claassen JAHR. Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol. 2014;71(8):971-977.
44.
Lucey BP, Hicks TJ, McLeland JS, et al. Effect of sleep on overnight cerebrospinal fluid amyloid β kinetics. Ann Neurol. 2018;83(1):197-204.
45.
Naismith S, Leng Y, Palmer JR, Lucey BP. Age differences in the association between sleep and Alzheimer's disease biomarkers in the EPAD cohort. Alzheimers Dement (Amst). 2022;14(1):e12380.
46.
Leng Y, McEvoy CT, Allen IE, Yaffe K. Association of sleep-disordered breathing with cognitive function and risk of cognitive impairment: a systematic review and meta-analysis. JAMA Neurol. 2017;74(10):1237-1245.
47.
Makarem N, Alcántara C, Williams N, Bello NA, Abdalla M. Effect of sleep disturbances on blood pressure. Hypertension. 2021;77(4):1036-1046.
48.
Vallat R, Shah VD, Redline S, Attia P, Walker MP. Broken sleep predicts hardened blood vessels. PLoS Biol. 2020;18(6):e3000726.
49.
Leng Y, Cappuccio FP, Wainwright NWJ, et al. Sleep duration and risk of fatal and nonfatal stroke: a prospective study and meta-analysis. Neurology. 2015;84(11):1072-1079.
50.
Yaffe K, Bahorik AL, Hoang TD, et al. Cardiovascular risk factors and accelerated cognitive decline in midlife: the CARDIA Study. Neurology. 2020;95(7):e839-e846.

Information & Authors

Information

Published In

Neurology®
Volume 102Number 2January 23, 2024
PubMed: 38170947

Publication History

Received: May 3, 2023
Accepted: October 16, 2023
Published online: January 3, 2024
Published in print: January 23, 2024

Permissions

Request permissions for this article.

Disclosure

The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.

Study Funding

The Coronary Artery Risk Development in Young Adults Study (CARDIA) is supported by contracts HHSN268201800003I, HHSN268201800004I, HHSN268201800005I, HHSN268201800006I, and HHSN268201800007I from the National Heart, Lung, and Blood Institute (NHLBI). Y. Leng is supported by NIA R00 AG056598. The CARDIA Cognitive Function ancillary study is supported by NHLBI grant R01 HL122658. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Authors

Affiliations & Disclosures

From the Department of Psychiatry and Behavioral Sciences (Y.L., K.Y.), Neurology (K.Y.), and Epidemiology (K.Y.), University of California, San Francisco; Departments of Neurology (K.K.) and Preventive Medicine (M.R.C.), Northwestern University Feinberg School of Medicine, Chicago, IL; and VA Medical Center (K.Y.), San Francisco, CA.
Disclosure
Financial Disclosure:
1.
NONE
Research Support:
1.
Governmental entities - NIA (R00AG056598): Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
Stock, Stock Options & Royalties:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Psychiatry and Behavioral Sciences (Y.L., K.Y.), Neurology (K.Y.), and Epidemiology (K.Y.), University of California, San Francisco; Departments of Neurology (K.K.) and Preventive Medicine (M.R.C.), Northwestern University Feinberg School of Medicine, Chicago, IL; and VA Medical Center (K.Y.), San Francisco, CA.
Disclosure
Financial Disclosure:
1.
Governmental - National Institutes of Health (1R01HL141881, 1R01AG059291, R01HL152442): My research is funded by research grants from the NIH.
Research Support:
1.
NONE
Stock, Stock Options & Royalties:
1.
NONE
Legal Proceedings:
1.
NONE
Mercedes R. Carnethon, PhD https://orcid.org/0000-0001-7035-0848
From the Department of Psychiatry and Behavioral Sciences (Y.L., K.Y.), Neurology (K.Y.), and Epidemiology (K.Y.), University of California, San Francisco; Departments of Neurology (K.K.) and Preventive Medicine (M.R.C.), Northwestern University Feinberg School of Medicine, Chicago, IL; and VA Medical Center (K.Y.), San Francisco, CA.
Disclosure
Financial Disclosure:
1.
NONE
Research Support:
1.
NONE
Stock, Stock Options & Royalties:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Psychiatry and Behavioral Sciences (Y.L., K.Y.), Neurology (K.Y.), and Epidemiology (K.Y.), University of California, San Francisco; Departments of Neurology (K.K.) and Preventive Medicine (M.R.C.), Northwestern University Feinberg School of Medicine, Chicago, IL; and VA Medical Center (K.Y.), San Francisco, CA.
Disclosure
Financial Disclosure:
1.
NONE
Research Support:
1.
NONE
Stock, Stock Options & Royalties:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Leng [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Associate Editor Barbara Jobst, MD, PhD, FAAN.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Short Form

View Short Form

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share